Dopa and 3-O-methyldopa in cerebrospinal fluid of Parkinsonism patients during treatment with oral L-dopa.
D000284:Administration, Oral; D000368:Aged; D000641:Ammonia; D001565:Benzoates / Q000134:cerebrospinal fluid; D002490:Central Nervous System / Q000378:metabolism; D055598:Chemical Phenomena; D002621:Chemistry; D002855:Chromatography, Thin Layer; D003545:Cysteine; D006801:Humans
D001565:Benzoates; D000641:Ammonia; D003545:Cysteine